• Citer

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

par Cherny, Nathan NI;Sullivan, Richard;Dafni, Urania;Kerst, J.M.;Sobrero, Alberto;Zielinski, Christoph;de Vries, Elisabeth Ge E Liesbeth E.;Piccart-Gebhart, Martine
Référence Annals of oncology, 26, 8, page (1547-1573)
Publication Publié, 2015

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
Auteur:	Cherny, Nathan NI; Sullivan, Richard; Dafni, Urania; Kerst, J.M.; Sobrero, Alberto; Zielinski, Christoph; de Vries, Elisabeth Ge E Liesbeth E.; Piccart-Gebhart, Martine
Informations sur la publication:	Annals of oncology, 26, 8, page (1547-1573)
Statut de publication:	Publié, 2015
Sujet CREF:	Hématologie
	Cancérologie
Mots-clés:	Clinical benefit
	ESMO
	Tool
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0923-7534
	info:doi/10.1093/annonc/mdv249
	info:scp/84940648261